Growth hormone delivery devices: current features and potential for enhanced treatment adherence.
about
Patients' perceptions on the usability of the SurePal™ self-injection device for Omnitrope®: a questionnaire-based observational study conducted in paediatric patients in France.A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre
P2860
Growth hormone delivery devices: current features and potential for enhanced treatment adherence.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Growth hormone delivery device ...... enhanced treatment adherence.
@en
type
label
Growth hormone delivery device ...... enhanced treatment adherence.
@en
prefLabel
Growth hormone delivery device ...... enhanced treatment adherence.
@en
P2093
P2860
P1476
Growth hormone delivery device ...... enhanced treatment adherence.
@en
P2093
Anne-Marie Kappelgaard
Reiko Horikawa
Tilman R Rohrer
P2860
P356
10.1080/17425247.2017.1243526
P407
P577
2016-10-10T00:00:00Z